Hypoglycemia in type 1 diabetes mellitus

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 3, 2010, Pages 641-654

  Cryer, Philip E ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

Defective glucose counter regulation; Diabetes; Hypoglycemia; Hypoglycemia unawareness; Hypoglycemia associated autonomic failure in diabetes

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; TERBUTALINE;

ABSENCE OF SIDE EFFECTS; AUTONOMIC DYSFUNCTION; BEDTIME DOSAGE; BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; RISK REDUCTION;

EID: 77955763276     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2010.05.003     Document Type: Review

References (65)

1. Cryer P.E. The barrier of hypoglycemia in diabetes. Diabetes 2008, 57(12):3169-3176.
2. Cryer P.E. Hypoglycemia in diabetes. Pathophysiology, prevalence and prevention 2009, American Diabetes Association, Alexandria (VA).
3. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329(14):977-986.
4. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005, 353(25):2643-2653.
5. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009, 32(8):1378-1383.
6. Raju B., Arbelaez A.M., Breckenridge S.M., et al. Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments. J Clin Endocrinol Metab 2006, 91(6):2087-2092.
7. DeRosa M.A., Cryer P.E. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab 2004, 287(1):E32-E41.
8. Towler D.A., Havlin C.E., Craft S., et al. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993, 42(12):1791-1798.
9. Boyle P.J., Schwartz N.S., Shah S.D., et al. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 1988, 318(23):1487-1492.
10. Amiel S.A., Sherwin R.S., Simonson D.C., et al. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988, 37(7):901-907.
11. Cryer P.E. Hypoglycemia, functional brain failure, and brain death. J Clin Invest 2007, 117(4):868-870.
12. Heller S.R. Sudden death and hypoglycaemia. Diabetic Hypoglycemia 2008, 1(2):2-7. Available at:, Accessed October 10, 2008. http://www.hypodiab.com.
13. Adler G.K., Bonyhay I., Failing H., et al. Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes 2009, 58(2):360-366.
14. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007, 356(18):1842-1852.
15. Feltbower R.G., Bodansky H.J., Patterson C.C., et al. Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of diabetes in children and young adults. Diabetes Care 2008, 31(5):922-926.
16. Skrivarhaug T., Bangstad H.J., Stene L.C., et al. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006, 49(2):298-305.
17. American Diabetes Association Workgroup on Hypoglycemia Defining and reporting hypoglycemia in diabetes. Diabetes Care 2005, 28(5):1245-1249.
18. Cryer P.E. Preventing hypoglycaemia: what is the appropriate glucose alert value?. Diabetologia 2009, 52(1):35-37.
19. Cryer P.E. The prevention and correction of hypoglycemia. In Handbook of physiology. Section 7, The endocrine system. The endocrine pancreas and regulation of metabolism 2001, vol. II:1057-1092. Oxford University Press, New York. L.S. Jefferson, A.D. Cherrington (Eds.).
20. Cryer P.E. Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes. J Clin Invest 2006, 116(6):1470-1473.
21. Dagogo-Jack S.E., Craft S., Cryer P.E. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 1993, 91(3):819-828.
22. Gerich J.E., Langlois M., Noacco C., et al. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973, 182(108):171-173.
23. Raju B., Cryer P.E. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes. Diabetes 2005, 54(3):757-764.
24. Cooperberg B.A., Cryer P.E. Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans. Diabetes Care 2009, 32(12):2275-2280.
25. Heller S.R., Cryer P.E. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 1991, 40(2):223-226.
26. White N.H., Skor D.A., Cryer P.E., et al. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 1983, 308(9):485-491.
27. Bolli G.B., De Feo P., De Cosmo S., et al. A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes 1984, 33(8):732-737.
28. Geddes J., Schopman J.E., Zammitt N.N., et al. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med 2008, 25(4):501-504.
29. Fanelli C.G., Epifano L., Rambotti A.M., et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993, 42(11):1683-1689.
30. Fanelli C., Pampanelli S., Epifano L., et al. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 1994, 37(12):1265-1276.
31. Cranston I., Lomas J., Maran A., et al. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994, 344(8918):283-287.
32. Dagogo-Jack S., Rattarasarn C., Cryer P.E. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994, 43(12):1426-1434.
33. Arbelaez A.M., Powers W.J., Videen T.O., et al. Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure. Diabetes 2008, 5(2):470-475.
34. Cryer P.E., Davis S.N., Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003, 26(6):1902-1912.
35. The Diabetes Control and Complications Trial Research Group Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991, 90(4):450-459.
36. Davis S., Alonso M.D. Hypoglycemia as a barrier to glycemic control. J Diabetes Complications 2004, 18(1):60-68.
37. Rossetti P., Porcellati F., Bolli G.B., et al. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs. Diabetes Care 2008, 31(Suppl 2):S113-S120.
38. Gonder-Frederick L.A., Fisher C.D., Ritterband L.M., et al. Predictors of fear of hypoglycemia in adolescents with type 1 diabetes and their parents. Pediatr Diabetes 2006, 7(4):215-222.
39. The U.K., Hypoglycaemia Study Group Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007, 50(6):1140-1147.
40. Cox D.J., Kovatchev B., Koev D., et al. Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int J Behav Med 2004, 11(4):212-218.
41. Cox D.J., Gonder-Frederick L., Ritterband L., et al. Prediction of severe hypoglycemia. Diabetes Care 2007, 30(6):1370-1373.
42. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008, 359(14):1464-1476.
43. Hirsch I.B. Insulin analogues. N Engl J Med 2005, 352(2):174-183.
44. Gough S.C.L. A review of human and analogue insulin trials. Diabetes Res Clin Pract 2007, 77(1):1-15.
45. Fatourechi M.M., Kudva Y.C., Murad M.H., et al. Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 2009, 94(3):729-740.
46. Bolli G.B., Kerr D., Thomas R., et al. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study. Diabetes Care 2009, 32(7):1170-1176.
47. Mukhopadhyay A., Farrell T., Fraser R.B., et al. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007, 197(5):447-456.
48. The Diabetes Control and Complications Trial Research Group Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997, 46(2):271-286.
49. Tsalikian E., Mauras N., Beck R.W., et al. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr 2005, 147(4):528-534.
50. Jones T.W., Porter P., Sherwin R.S., et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998, 338(23):1657-1662.
51. Banarer S., Cryer P.E. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes 2003, 52(5):1195-1203.
52. Schultes B., Jauch-Chara K., Gais S., et al. Defective awakening response to nocturnal hypoglycemia in patients with type 1 diabetes mellitus. PLoS Med 2007, 4(2):e69.
53. Cooperberg B.A., Breckenridge S.M., Arbelaez A.M., et al. Terbutaline and the prevention of nocturnal hypoglycemia in type 1 diabetes. Diabetes Care 2008, 31(12):2271-2272.
54. Ertl A.C., Davis S.N. Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus. Diabetes Metab Res Rev 2004, 20(2):124-130.
55. Tansey M.J., Tsalikian E., Beck R.W., et al. The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care 2006, 29(1):20-25.
56. MacDonald M.J. Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care 1987, 10(5):584-588.
57. Sandoval D.A., Guy D.L., Richardson M.A., et al. Effects of low and moderate antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes. Diabetes 2004, 53(7):1798-1806.
58. Cryer P.E., Axelrod L., Grossman A.B., et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009, 94(3):709-728.
59. American Diabetes Association Standards of medical care in diabetes-2009. Diabetes Care 2009, 32(Suppl 1):S13-S61.
60. Skyler J.S., Bergenstal R., Bonow R.O., et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials. Diabetes Care 2009, 32(1):187-192.
61. Lachin J.M., Genuth S., Nathan D.M., et al. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial: revisited. Diabetes 2008, 57(4):995-1001.
62. Huang E.S., Zhang Q., Gandra N., et al. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med 2008, 149(1):11-19.
63. Hopkins D., Lawrence I., Mansell P., et al. Routine structured education reduces HbA1C and hypoglycemia and improves psychological health in patients with type 1 diabetes mellitus [abstract]. Diabetes 2008, 57(Suppl 1):A37.
64. Wiethop B.V., Cryer P.E. Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 1993, 16(8):1131-1136.
65. Haymond M.W., Schreiner B. Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes. Diabetes Care 2001, 24(4):643-645.